What are the cardiovascular manifestations of Fibromuscular Dysplasia (FMD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Fibromuscular dysplasia (FMD) is a systemic disease that affects multiple vascular beds, leading to various cardiovascular manifestations, including renovascular hypertension, cerebrovascular symptoms, coronary artery disease, and peripheral artery involvement. The most common cardiovascular manifestation is renovascular hypertension, occurring when FMD affects the renal arteries, leading to reduced kidney perfusion and activation of the renin-angiotensin-aldosterone system 1. Patients may also develop cerebrovascular symptoms like headaches, pulsatile tinnitus, and stroke when carotid or vertebral arteries are involved. Coronary artery FMD can cause chest pain, myocardial infarction, or sudden cardiac death. Other manifestations include mesenteric ischemia causing abdominal pain after eating, and peripheral artery involvement leading to claudication or critical limb ischemia.

Diagnosis and Management

Diagnosis typically involves imaging studies such as CT angiography, MR angiography, or catheter-based angiography showing the characteristic "string of beads" appearance. Management includes:

  • Blood pressure control with antihypertensive medications (particularly ACE inhibitors or ARBs) 1
  • Antiplatelet therapy with aspirin 81-325mg daily 1
  • In severe cases, revascularization procedures like angioplasty may be necessary 1 Regular cardiovascular monitoring is essential as FMD patients have higher rates of aneurysms and dissections throughout the arterial system.

Key Considerations

  • FMD can involve multiple vascular beds, including the carotid, vertebral, renal, and coronary arteries 1
  • Patients with FMD are at increased risk of ischemic events, and antiplatelet therapy and blood pressure control are recommended to prevent future events 1
  • Revascularization procedures like angioplasty may be necessary in severe cases, but should be performed in experienced centers due to the high risk of restenosis 1

From the Research

Cardiovascular Manifestations of Fibromuscular Hyperplasia

The cardiovascular manifestations of fibromuscular hyperplasia, also known as fibromuscular dysplasia (FMD), can be severe and varied. Some of the key manifestations include:

  • Hypertension due to renal artery involvement 2, 3, 4, 5, 6
  • Transient ischemic attack or stroke due to carotid or vertebral artery involvement 2, 3, 6
  • Asymptomatic cervical bruit 6
  • Ischemic stroke or transient ischemic attack when the disease affects the carotid or vertebral arteries 2

Treatment Options

Treatment options for FMD vary depending on the location and severity of the disease. Some of the treatment options include:

  • Percutaneous transluminal angioplasty (PTA) for patients with renal artery stenosis causing hypertension 2, 3, 4, 5, 6
  • Antiplatelet agents for patients with cerebrovascular FMD 3
  • Surgery for patients with severe or complex disease 4, 5
  • Conservative therapy for patients with asymptomatic and extensive lesions of the carotid arteries 2

Outcomes

The outcomes of treatment for FMD can be significant, with some studies showing:

  • Decreased blood pressure and improved blood pressure control 4, 5
  • Reduced need for antihypertensive medications 4
  • Improved renal function 4
  • Cure or improvement of hypertension in a significant proportion of patients 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fibromuscular Dysplasia of Renal and Carotid Arteries.

The International journal of angiology : official publication of the International College of Angiology, Inc, 2015

Research

Fibromuscular Dysplasia.

Current treatment options in cardiovascular medicine, 2005

Research

Recognizing and managing fibromuscular dysplasia.

Cleveland Clinic journal of medicine, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.